KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amgen (AMGN) EBITDA (2016 - 2025)

Amgen (AMGN) has 17 years of EBITDA data on record, last reported at $2.7 billion in Q4 2025.

  • For Q4 2025, EBITDA rose 17.7% year-over-year to $2.7 billion; the TTM value through Dec 2025 reached $9.1 billion, up 25.1%, while the annual FY2025 figure was $9.1 billion, 25.1% up from the prior year.
  • EBITDA reached $2.7 billion in Q4 2025 per AMGN's latest filing, up from $2.5 billion in the prior quarter.
  • Across five years, EBITDA topped out at $2.7 billion in Q4 2025 and bottomed at $828.0 million in Q2 2021.
  • Average EBITDA over 5 years is $2.1 billion, with a median of $2.2 billion recorded in 2022.
  • Peak YoY movement for EBITDA: plummeted 64.36% in 2021, then skyrocketed 162.8% in 2022.
  • A 5-year view of EBITDA shows it stood at $2.3 billion in 2021, then fell by 3.21% to $2.2 billion in 2022, then crashed by 43.0% to $1.3 billion in 2023, then soared by 81.83% to $2.3 billion in 2024, then rose by 17.7% to $2.7 billion in 2025.
  • Per Business Quant database, its latest 3 readings for EBITDA were $2.7 billion in Q4 2025, $2.5 billion in Q3 2025, and $2.7 billion in Q2 2025.